About ONC
With continuous growth since our establishment in 1992, we have now become one of the largest local law firms with more than 130 members of legally-qualified and supporting staff.
Our firm is a member of International Society of Primerus Law Firms, an international network of the world’s finest law firms. With the seamless support of 200 member firms in more than 40 countries, we are able to assist our clients and serve their needs in major jurisdictions all over the world.
ONC Lawyers has been recognized by AsiaLaw Profiles as a “Highly Recommended Law Firm” in Hong Kong. We are also recognized by Chambers and Partners as a “Leading Firm”. ONC Lawyers also received the “Debt Market Deal of the Year” Award in the Macallan ALB Hong Kong Law Awards 2018.
News & Events
-
Mr Dominic Wai will be one of the panel speakers in the “6th International Arbitration, Corporate Fraud & Anti-Trust Summit – Hong Kong” organised by LegalPlus
Our Partner Mr Dominic Wai will be one of the panel speakers at the “6th International Arbitration, Corporate Fraud & Anti-Trust Summit – Hong Kong” organised by LegalPlus, speaking on the topic "From Data Chaos to Defensible Evidence: Legal Technology and eDiscovery for Arbitration, Fraud and Antitrust in Asia". The event will be held on 24 June 2026 at KPMG’s Hong Kong office.
For the full programme and registration, please click here.
2026-06
-
Mr Ludwig Ng is interviewed by HKEJ urging the introduction of corporate rescue legislation in Hong Kong
Our Senior Partner, Mr Ludwig Ng, and Chairman of the Restructuring and Insolvency Faculty of HKICPA, Mr Daniel Chow, have been recently interviewed by the Hong Kong Economic Journal (HKEJ), analysing the reasons why corporate rescue legislation is needed in Hong Kong and urging for its reconsideration. The feature story entitled ‘立法救企業冷待 30 年 業界倡復議’ (‘Industry urges reconsideration of corporate rescue legislation that has been shelved for 30 years’) is published in HKEJ on 9 June 2026.
For PDF version, please click here.
2026-06
-
ONC Lawyers advised on the 18A listing of LongBio Pharma (Suzhou) Co., Ltd.
ONC Lawyers is proud to have acted as the Hong Kong legal advisers to LongBio Pharma (Suzhou) Co., Ltd. (Stock Code: 01779) in its global offering and listing of H Shares on the Main Board of The Stock Exchange of Hong Kong Limited. Trading in the H Shares commenced on 5 June 2026. At the time of listing, LongBio Pharma has achieved a market capitalisation of approximately HK$7.01 billion, based on 72,930,268 H Shares in issue and an offer price of HK$96.06 per H Share.
LongBio Pharma is a clinical-stage biopharmaceutical company. Established in 2020 and located in Shanghai and Changshu, Suzhou, China, it primarily focuses on in-house discovery and development of biopharmaceuticals targeting allergic and autoimmune diseases. It has developed a comprehensive product pipeline for biologic treatments targeting rhinology, dermatology, respiratory, hematology, nephrology and other autoimmune diseases.
ONC team was led by Ms. Angel Wong (Partner) with the support from Mr. Paul Lam (Partner), Ms. Joey Chan (Associate), Ms. Cyran Chen (Trainee Solicitor) and Ms. Sunny Tsang (Corporate Paralegal).
This listing represents a landmark transaction for ONC in the life sciences and healthcare sector. Looking ahead, ONC will continue to leverage its industry insight and professional expertise to support more innovative enterprises in accessing the capital markets and achieving breakthrough growth.
2026-06
